NEW YORK, Oct. 22, 2024 (GLOBE NEWSWIRE) -- Cayson Acquisition Corp (NASDAQ:CAPNU) (the “Company”) announced today that, commencing on or about October 24, 2024, holders of its units sold in the...
NEW YORK, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Cayson Acquisition Corp (the “Company”) announced today that it priced its initial public offering of 6,000,000 units at $10.00 per unit. The...
REDWOOD CITY, Calif., July 24, 2017 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (NASDAQ:SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of...
Positive guidance received on key elements of Phase III programCompany expects to initiate pivotal Phase III clinical trial by year-end 2017DCCR has orphan designation for the treatment of PWS...
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.0195 | -0.194029850746 | 10.05 | 10.1 | 10.01 | 14838 | 10.02891626 | CS |
4 | 0.0405 | 0.405405405405 | 9.99 | 10.1 | 9.98 | 13670 | 10.00434425 | CS |
12 | 9.3305 | 1332.92857143 | 0.7 | 10.18 | 0.7 | 26469 | 9.97853094 | CS |
26 | 9.3305 | 1332.92857143 | 0.7 | 10.18 | 0.7 | 11994 | 9.97853094 | CS |
52 | 9.3305 | 1332.92857143 | 0.7 | 10.18 | 0.7 | 6092 | 9.97853094 | CS |
156 | 9.3305 | 1332.92857143 | 0.7 | 10.18 | 0.7 | 2031 | 9.97853094 | CS |
260 | 9.3305 | 1332.92857143 | 0.7 | 10.18 | 0.7 | 1437 | 9.97853094 | CS |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約